Home › Companies › Disc Medicine, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Disc Medicine, Inc.’s Form 8-K, filed June 24, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 18, 2026: 5 items on Disc Medicine, Inc.’s Form 8-K, filed June 24, 2026: 2 approved · 3 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Disc Medicine, Inc. in the interactive database Compare manager voting policies
These tallies are Disc Medicine, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Donald Nicholson, Ph.D. | 28,559,799 | -- | -- | 5,347,450 | 2,011,469 | 84% | Not verified | — |
| Elect Director: John Quisel, J.D., Ph.D. | 33,433,078 | -- | -- | 474,171 | 2,011,469 | 99% | Not verified | — |
| Elect Director: William White, M.P.P., J.D. | 33,355,406 | -- | -- | 551,843 | 2,011,469 | 98% | Not verified | — |
| 2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers | 33,528,449 | 368,970 | 9,830 | -- | 2,011,469 | 99% | Approved | — |
| 3. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm | 35,908,900 | 1,298 | 8,520 | -- | -- | 99.9% | Approved | — |
Source: Disc Medicine, Inc., Form 8-K, filed with the SEC on June 24, 2026 — read the filing on EDGAR.
Each item below shows how the 221 asset managers that disclosed a Disc Medicine, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.
Disc Medicine, Inc.’s own tally for this item (“Elect Director: Donald Nicholson, Ph.D.”): 28,559,799 for, 5,347,450 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 66 asset managers below reported 11,355,556 for, 1,647,909 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,922,061 | 0 | 0 | 0 | For |
| Vanguard | 1,608,863 | 0 | 12 | 4,349 | For |
| T. Rowe Price | 976,664 | 0 | 0 | 0 | For |
| JPMorgan | 824,999 | 0 | 0 | 0 | For |
| State Street | 588 | 0 | 0 | 795,244 | Withhold |
| BlackRock | 460,868 | 0 | 0 | 1,607 | For |
| MUTUAL FUND SERIES TRUST | 395,235 | 0 | 0 | 3,972 | For |
| Charles Schwab | 252,649 | 0 | 0 | 0 | For |
| Prudential/PGIM | 198,021 | 0 | 0 | 1,202 | For |
| Hartford | 186,166 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 0 | 172,923 | Withhold |
| Dimensional | 0 | 0 | 0 | 165,288 | Withhold |
| Jackson National | 105,034 | 0 | 0 | 5,727 | Mixed |
| Northwestern Mutual | 88,548 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 86,107 | Withhold |
| Victory Capital | 741 | 0 | 0 | 83,651 | Withhold |
| Brighthouse | 40,097 | 0 | 0 | 39,344 | Mixed |
| BNY Mellon | 58,805 | 0 | 0 | 986 | For |
| Equitable | 58,050 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 49,232 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 44,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 42,892 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 36,019 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 31,714 | Withhold |
| ProShares | 0 | 0 | 0 | 29,025 | Withhold |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.
Disc Medicine, Inc.’s own tally for this item (“Elect Director: John Quisel, J.D., Ph.D.”): 33,433,078 for, 474,171 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 66 asset managers below reported 12,823,418 for, 180,058 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,922,061 | 0 | 0 | 0 | For |
| Vanguard | 1,610,310 | 0 | 1 | 2,913 | For |
| T. Rowe Price | 976,664 | 0 | 0 | 0 | For |
| JPMorgan | 824,999 | 0 | 0 | 0 | For |
| State Street | 794,783 | 0 | 0 | 1,049 | For |
| BlackRock | 462,475 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 399,207 | 0 | 0 | 0 | For |
| Charles Schwab | 252,649 | 0 | 0 | 0 | For |
| Prudential/PGIM | 198,021 | 0 | 0 | 1,202 | For |
| Hartford | 186,166 | 0 | 0 | 0 | For |
| Loomis Sayles | 172,923 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 165,288 | Withhold |
| Jackson National | 105,034 | 0 | 0 | 5,727 | Mixed |
| Northwestern Mutual | 88,548 | 0 | 0 | 0 | For |
| Aberdeen | 86,107 | 0 | 0 | 0 | For |
| Victory Capital | 84,392 | 0 | 0 | 0 | For |
| Brighthouse | 79,123 | 0 | 0 | 318 | For |
| BNY Mellon | 59,791 | 0 | 0 | 0 | For |
| Equitable | 58,050 | 0 | 0 | 0 | For |
| TIAA | 49,232 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 42,892 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 36,019 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 31,714 | 0 | 0 | 0 | For |
| ProShares | 29,025 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.
Disc Medicine, Inc.’s own tally for this item (“Elect Director: William White, M.P.P., J.D.”): 33,355,406 for, 551,843 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 66 asset managers below reported 12,821,981 for, 181,494 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,922,061 | 0 | 0 | 0 | For |
| Vanguard | 1,608,874 | 0 | 1 | 4,349 | For |
| T. Rowe Price | 976,664 | 0 | 0 | 0 | For |
| JPMorgan | 824,999 | 0 | 0 | 0 | For |
| State Street | 794,783 | 0 | 0 | 1,049 | For |
| BlackRock | 462,475 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 399,207 | 0 | 0 | 0 | For |
| Charles Schwab | 252,649 | 0 | 0 | 0 | For |
| Prudential/PGIM | 198,021 | 0 | 0 | 1,202 | For |
| Hartford | 186,166 | 0 | 0 | 0 | For |
| Loomis Sayles | 172,923 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 165,288 | Withhold |
| Jackson National | 105,034 | 0 | 0 | 5,727 | Mixed |
| Northwestern Mutual | 88,548 | 0 | 0 | 0 | For |
| Aberdeen | 86,107 | 0 | 0 | 0 | For |
| Victory Capital | 84,392 | 0 | 0 | 0 | For |
| Brighthouse | 79,123 | 0 | 0 | 318 | For |
| BNY Mellon | 59,791 | 0 | 0 | 0 | For |
| Equitable | 58,050 | 0 | 0 | 0 | For |
| TIAA | 49,232 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 42,892 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 36,019 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 31,714 | 0 | 0 | 0 | For |
| ProShares | 29,025 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 9 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Disc Medicine, Inc.’s own tally for this item (“2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers”): 33,528,449 for, 368,970 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers as described in the Proxy Statement.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,922,061 | 0 | 0 | 0 | For |
| Vanguard | 1,613,223 | 1 | 0 | 0 | For |
| T. Rowe Price | 976,664 | 0 | 0 | 0 | For |
| JPMorgan | 824,999 | 0 | 0 | 0 | For |
| State Street | 795,522 | 310 | 0 | 0 | For |
| BlackRock | 462,475 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 399,207 | 0 | 0 | 0 | For |
| Charles Schwab | 252,649 | 0 | 0 | 0 | For |
| Prudential/PGIM | 199,223 | 0 | 0 | 0 | For |
| Hartford | 186,166 | 0 | 0 | 0 | For |
| Loomis Sayles | 172,923 | 0 | 0 | 0 | For |
| Dimensional | 165,288 | 0 | 0 | 0 | For |
| Jackson National | 110,761 | 0 | 0 | 0 | For |
| Northwestern Mutual | 88,548 | 0 | 0 | 0 | For |
| Aberdeen | 86,107 | 0 | 0 | 0 | For |
| Victory Capital | 84,392 | 0 | 0 | 0 | For |
| Brighthouse | 79,123 | 0 | 318 | 0 | For |
| BNY Mellon | 59,791 | 0 | 0 | 0 | For |
| Equitable | 58,050 | 0 | 0 | 0 | For |
| TIAA | 49,232 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 42,892 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 36,019 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 31,714 | 0 | 0 | 0 | For |
| ProShares | 29,025 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 12,996,976 for, 5,529 against, 318 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,409,320 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,577,106 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 1,513,875 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,393,866 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 1,354,852 | 0 | 0 | 0 | For |
| BVF INC/IL | 1,272,312 | 0 | 0 | 0 | For |
| State Street | 1,134,054 | 1,047 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,064,864 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 988,401 | 0 | 0 | 0 | For |
| Wellington | 896,984 | 0 | 0 | 0 | For |
| Woodline Partners LP | 767,349 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 623,454 | 0 | 0 | 0 | For |
| BlackRock | 548,935 | 2,317 | 81 | 0 | For |
| Vestal Point Capital, LP | 491,110 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 479,750 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 410,121 | 0 | 0 | 0 | For |
| Aberdeen | 388,534 | 0 | 0 | 0 | For |
| Foresite Capital Management V, LLC | 374,069 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 346,513 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 318,604 | 0 | 0 | 0 | For |
| Loomis Sayles | 300,588 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 267,399 | 0 | 0 | 0 | For |
| Charles Schwab | 252,696 | 0 | 0 | 0 | For |
| Vanguard | 250,852 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 245,445 | 0 | 0 | 0 | For |
Institutional-manager reports, all 177 managers: 24,540,532 for, 198,325 against, 158 abstained, 55 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Disc Medicine, Inc.’s own tally for this item (“3. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 35,908,900 for, 1,298 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 66 asset managers below reported 13,003,159 for, 318 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,922,061 | 0 | 0 | 0 | For |
| Vanguard | 1,613,224 | 0 | 0 | 0 | For |
| T. Rowe Price | 976,664 | 0 | 0 | 0 | For |
| JPMorgan | 824,999 | 0 | 0 | 0 | For |
| State Street | 795,832 | 0 | 0 | 0 | For |
| BlackRock | 462,475 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 399,207 | 0 | 0 | 0 | For |
| Charles Schwab | 252,649 | 0 | 0 | 0 | For |
| Prudential/PGIM | 199,223 | 0 | 0 | 0 | For |
| Hartford | 186,166 | 0 | 0 | 0 | For |
| Loomis Sayles | 172,923 | 0 | 0 | 0 | For |
| Dimensional | 165,288 | 0 | 0 | 0 | For |
| Jackson National | 110,761 | 0 | 0 | 0 | For |
| Northwestern Mutual | 88,548 | 0 | 0 | 0 | For |
| Aberdeen | 86,107 | 0 | 0 | 0 | For |
| Victory Capital | 84,392 | 0 | 0 | 0 | For |
| Brighthouse | 79,123 | 0 | 318 | 0 | For |
| BNY Mellon | 59,791 | 0 | 0 | 0 | For |
| Equitable | 58,050 | 0 | 0 | 0 | For |
| TIAA | 49,232 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 44,503 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 42,892 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 36,019 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 31,714 | 0 | 0 | 0 | For |
| ProShares | 29,025 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 38,190,464 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 15.51% |
| 2 | Vanguard | 4.22% |
| 3 | T. Rowe Price | 2.56% |
| 4 | JPMorgan | 2.16% |
| 5 | State Street | 2.08% |
| 6 | BlackRock | 1.21% |
| 7 | MUTUAL FUND SERIES TRUST | 1.05% |
| 8 | Charles Schwab | 0.66% |
| 9 | Prudential/PGIM | 0.52% |
| 10 | Hartford | 0.49% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.16% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 4.13% |
| 3 | Atlas Venture Life Science Advisors, LLC | 3.96% |
| 4 | T. Rowe Price | 3.65% |
| 5 | Frazier Life Sciences Management, L.P. | 3.55% |
| 6 | BVF INC/IL | 3.33% |
| 7 | State Street | 2.97% |
| 8 | ORBIMED ADVISORS LLC | 2.79% |
| 9 | Siren, L.L.C. | 2.59% |
| 10 | Wellington | 2.35% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.63% | 13F |
| FMR LLC | 13.88% | DEF14A |
| AI DMI LLC | 7.90% | DEF14A |
| BlackRock | 5.95% | 13F |
| RA Capital Management, L.P. | 5.84% | DEF14A |
| Vanguard Group | 4.63% | 13F |
| State Street | 4.45% | 13F |
| T. Rowe Price | 4.06% | 13F |
| JPMorgan Chase | 3.59% | 13F |
| Geode Capital | 1.95% | 13F |
Percentages above are of 38,190,464 shares outstanding, as reported by Disc Medicine, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Disc Medicine, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Disc Medicine, Inc.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 221 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,360 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED… — Disc Medicine, Inc.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Disc Medicine, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2026.
Disc Medicine, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.